To include your compound in the COVID-19 Resource Center, submit it here.

AquaMed Technologies Inc., HepaLife Technologies deal

HepaLife completed its previously announced acquisition of drug delivery company AquaMed in a stock deal.

Read the full 153 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE